Please Note:
This profile was automatically generated using 36 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 36 references found on the Internet. This information has not been verified. Learn more...
View all 36 references Web References
-
1. Feinstein Partners, Inc.
www.prnewswire.com/gh/cnoc/com - [Cached]Published on: 12/1/2004 Last Visited: 12/1/2004
ZymoGenetics Appoints Frank Collins, Ph.D. as Senior Vice President of Research -
2. NEWS RELEASE ARCHIVE
www.zymogenetics.com/ir/news-a - [Cached]Last Visited: 4/1/2008
ZymoGenetics Appoints Frank Collins, Ph.D. as Senior Vice President of Research -
3. www.zgi.com
www.zgi.com/ir/newsItem.php?id - [Cached]Published on: 7/17/2003 Last Visited: 12/29/2007
"CTRP1 is a potent local acting anti-thrombotic yet appears to lack any systemic effect on blood coagulation, reducing concerns for bleeding complications associated with its use," stated Frank Collins, Ph.D., Senior Vice President and Chief Scientific Officer of ZymoGenetics.
